CORONAVAC Trademark

Trademark Overview


On Friday, August 7, 2020, a trademark application was filed for CORONAVAC with the United States Patent and Trademark Office. The USPTO has given the CORONAVAC trademark a serial number of 79302613. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, April 1, 2022. This trademark is owned by Sinovac Life Sciences Co., Ltd.. The CORONAVAC trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; biological tissue cultures for medical purposes; nutraceuticals for the treatment of infectious diseases; depuratives for the body; pharmaceutical preparations, namely, antivirals; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological preparations for the treatment of cancer; mixed biological preparations for the prevention and treatment of infectious diseases; antibiotics for human use; pharmaceutical preparations, namely, an analgesic for human consumption taken orally; medicinal infusions for treating infectious diseases; medicated serums for treatment of infectious diseases; dietetic foods adapted for...
coronavac

General Information


Serial Number79302613
Word MarkCORONAVAC
Filing DateFriday, August 7, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, April 1, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesVaccines; biological tissue cultures for medical purposes; nutraceuticals for the treatment of infectious diseases; depuratives for the body; pharmaceutical preparations, namely, antivirals; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological preparations for the treatment of cancer; mixed biological preparations for the prevention and treatment of infectious diseases; antibiotics for human use; pharmaceutical preparations, namely, an analgesic for human consumption taken orally; medicinal infusions for treating infectious diseases; medicated serums for treatment of infectious diseases; dietetic foods adapted for medical use; nutritional supplements, all the aforementioned goods used for the treatment and prevention of the coronavirus or COVID-19
Pseudo MarkCORONA VACCINES

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 28, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSinovac Life Sciences Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Monday, April 24, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, April 3, 2023FINAL DISPOSITION NOTICE SENT TO IB
Saturday, April 1, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, July 11, 2022NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, June 22, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 22, 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, April 1, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, April 1, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, April 1, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, August 24, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, August 24, 2021FINAL REFUSAL E-MAILED
Tuesday, August 24, 2021FINAL REFUSAL WRITTEN
Monday, July 12, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 12, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 12, 2021ASSIGNED TO LIE
Friday, May 28, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 23, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 23, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 23, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, April 23, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 23, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 23, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, March 7, 2021REFUSAL PROCESSED BY IB
Thursday, February 18, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, February 18, 2021REFUSAL PROCESSED BY MPU
Saturday, February 6, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, February 5, 2021NON-FINAL ACTION WRITTEN
Tuesday, February 2, 2021APPLICATION FILING RECEIPT MAILED
Thursday, January 28, 2021ASSIGNED TO EXAMINER
Thursday, January 28, 2021ASSIGNED TO EXAMINER
Thursday, January 28, 2021ASSIGNED TO EXAMINER
Thursday, January 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 27, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, January 21, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB